Camaisa Allan 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-25 6:46 pm Purchase | 2023-09-12 | 13D | Calidi Biotherapeutics, Inc. CLDI | Camaisa Allan | 1,203,730 30.900% | 1,203,730 (New Position) | Filing |